Market Overview

The Aerobika device can help patients with COPD / Chronic Bronchitis get their breath back.


LONDON, ONTARIO--(Marketwired - Nov. 19, 2015) -

Editor's Note: There are three photos associated with this release.

With the winter season upon us, patients with COPD or Chronic Bronchitis face an increased risk of exacerbation, or worsening of their symptoms. Cold weather, wind and exposure to colds and flu make it more likely that, from November to February, COPD symptoms could become more frequent and more severe.

While approximately 800,000 Canadians have been diagnosed with COPD, as many as 2.4 million are likely living with the disease without a formal diagnosis.(1) Symptoms include a long-lasting cough, a cough with mucus, shortness of breath, lung infections, difficulty walking long distances and challenges with performing daily tasks(2), all of which are often worse during the winter season. Simple tasks like blowing out candles, climbing stairs or sleeping through the night can be difficult.

The Aerobika(i) device, from Trudell Medical International, is drug-free, easy-to-use and clinically-supported to help COPD patients cope with their symptoms and improve their quality of life. It works by opening up the lungs and creating vibrations in the chest, which can help to thin and loosen excess mucus so it can be coughed out.

Recent studies, including a publication in the Journal of COPD from the University of Western Ontario reported that daily use of the Aerobika(i) device resulted in significant improvement in quality of life for mucus producing patients with COPD. Patients using the device daily showed improvement in the ease of expelling mucus, increased lung capacity, increased exercise tolerance and an improved quality of life after using the device for just 3-4 weeks.(3,4)

The Aerobika(i) device can be used in conjunction with existing COPD prescription medications and is widely available at retail pharmacies across Canada. Consult with your healthcare practitioner today about diagnosis and treatment and ask them how the Aerobika(i) device may help you.

To learn more about the Aerobika(i) device visit

November 18, 2015 was World COPD Day, a day dedicated to improving awareness and care of COPD around the world. COPD is a disease that is predicted to be the #3 killer globally by 2030. Trudell Medical International would like to remind those living with COPD that "It's Not Too Late" to take the positive steps that will help you breathe easier and have a better quality of life.

(i) trademarks and registered trademarks of Trudell Medical International.

1. Canadian Lung Association Statistics
2. on 30 Oct
3. COPD 0;1-9:2015
4. Eur Respir J 2014; P3679


TMI designs, develops and manufactures a wide range of medical devices, from our flagship AeroChamber(i) Brand of Valved Holding Chamber (VHC) for asthma patients and our latest state-of-the-art Aerobika(i) oPEP therapy system for COPD patients, to custom designed products and systems. Our best-in-class respiratory management products are sold in over 100 countries and their efficacy has been validated in hundreds of peer-reviewed articles from various medical journals. TMI is registered to ISO 13485-2003 certified, specific for medical device manufacturers.

To view the photos associated with this release, please visit the following links:

Jennifer Williams
Director of Marketing

View Comments and Join the Discussion!